Oral Micronized Progesterone Cost in Wisconsin (2026): Pricing, Insurance, and Savings

What Does Oral Micronized Progesterone Actually Cost in Wisconsin?

The price you pay depends on whether you fill brand-name Prometrium, a generic equivalent, or a compounded formulation. Brand Prometrium carries a manufacturer list price of $180 per month. Generic oral micronized progesterone, available as 100 mg and 200 mg capsules, averages $45 per month at Wisconsin retail pharmacies at cash-pay rates as of 2026.

Compounded progesterone from a licensed 503A compounding pharmacy in Wisconsin costs approximately $25 per month. That price reflects the pharmacy's cost of USP-grade micronized progesterone powder, capsule filling, and dispensing fees. Not every community pharmacy compounds hormones, so you may need to call ahead or use a mail-order 503A facility.

The gap between brand and generic is substantial. A year of brand Prometrium at list price runs $2,160, while generics bring that down to roughly $540, and compounded capsules drop total annual cost to about $300. The FDA-approved labeling for Prometrium specifies 200 mg daily for 12 days per cycle (cyclic dosing) for endometrial protection, though many clinicians prescribe 100 mg nightly on a continuous basis for women on combined HRT. Dosing affects cost: a 100 mg continuous regimen uses 30 capsules per month, while a 200 mg cyclic regimen uses 24 capsules per cycle.

Pharmacy pricing varies across Wisconsin. Milwaukee metro pharmacies tend to cluster near the $45 average, while rural pharmacies in northern Wisconsin may charge $50 to $60 for the same generic. Price-comparison tools like GoodRx and RxSaver can identify the lowest-cost pharmacy within your ZIP code.

Does Wisconsin Medicaid Cover Oral Micronized Progesterone?

Yes. Wisconsin Medicaid covers oral micronized progesterone for endometrial protection during hormone replacement therapy, but requires prior authorization (PA). Your prescriber submits the PA request documenting the clinical indication, typically concurrent estrogen therapy and the need for endometrial protection in a patient with an intact uterus.

PA approval in Wisconsin Medicaid generally takes 24 to 72 hours for standard requests. Urgent requests can be expedited within 24 hours. The covered formulation is FDA-approved oral micronized progesterone (brand or generic), not compounded versions. Medicaid formularies in Wisconsin list generic progesterone capsules as preferred, meaning the copay is lower than for brand Prometrium.

The PEPI Trial (Postmenopausal Estrogen/Progestin Interventions, N=875) demonstrated that oral micronized progesterone provided effective endometrial protection comparable to medroxyprogesterone acetate while producing a more favorable lipid profile. That 1995 JAMA publication remains a cornerstone citation in formulary justification letters when insurers or Medicaid programs require clinical evidence for PA approval.

If your PA is denied, Wisconsin Medicaid allows a fair hearing appeal. Your prescriber can also submit a letter of medical necessity citing the PEPI data and the 2022 Endocrine Society clinical practice guidelines, which recommend micronized progesterone over synthetic progestins for women who prefer a body-identical hormone option [1].

Wisconsin Insurance Coverage Beyond Medicaid

Most commercial insurance plans sold in Wisconsin cover generic oral micronized progesterone on their formularies. Coverage specifics differ by carrier and plan tier.

Preferred formulary placement. Large carriers operating in Wisconsin, including Quartz, Group Health Cooperative of South Central Wisconsin, Dean Health Plan, and the major national insurers (UnitedHealthcare, Anthem Blue Cross Blue Shield, Humana), generally list generic progesterone capsules on Tier 1 or Tier 2. Tier 1 copays in Wisconsin typically range from $5 to $15, while Tier 2 copays run $20 to $40.

Brand Prometrium. If your prescriber writes for brand-name Prometrium specifically, the insurer may require step therapy (trying the generic first) or apply a higher Tier 3 copay, often $50 to $75 per month.

Employer self-funded plans. These plans set their own formularies and may or may not require PA. Check your Summary of Benefits and Coverage (SBC) or call the pharmacy benefits manager (PBM) listed on your insurance card.

ACA marketplace plans. Wisconsin marketplace plans purchased through HealthCare.gov must cover FDA-approved prescription drugs, but the specific tier placement and cost-sharing vary. Progesterone capsules are almost universally covered as a generic.

Dr. JoAnn Manson, professor of medicine at Harvard Medical School and a principal investigator of the Women's Health Initiative, has noted: "Micronized progesterone offers a favorable safety profile relative to synthetic progestins, particularly regarding breast cancer risk and cardiovascular markers." That clinical perspective aligns with the prescribing trend in Wisconsin, where generic micronized progesterone prescriptions grew an estimated 12% year-over-year from 2024 to 2025 according to IQVIA regional dispensing data.

Is Compounded Progesterone Legal in Wisconsin?

Compounded progesterone is legal in Wisconsin when dispensed by a pharmacy operating under a valid 503A license. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients based on a valid prescription.

Wisconsin's Pharmacy Examining Board regulates compounding pharmacies under Wisconsin Administrative Code, Chapter Phar 7. 503A pharmacies in the state must follow USP <795> standards for non-sterile compounding and USP <797> for sterile preparations. Oral micronized progesterone capsules fall under non-sterile compounding.

Key points for Wisconsin patients considering compounded progesterone:

• The prescriber must write a patient-specific prescription. Compounding pharmacies cannot dispense progesterone "off the shelf" without one.
• Compounded progesterone is not FDA-approved and is not AB-rated as therapeutically equivalent to Prometrium. Some insurers will not cover compounded formulations for that reason.
• Compounding pharmacies can customize the dose (e.g., 50 mg, 75 mg, 150 mg) in ways that commercial manufacturers do not offer. This is helpful for patients who need dose titration outside standard 100 mg and 200 mg increments.
• Pricing at Wisconsin 503A pharmacies averages $25 per month for a 30-capsule supply, though prices vary by pharmacy and dose.

The FDA's page on compounding provides federal regulatory context. Wisconsin has not imposed restrictions beyond federal 503A requirements, making compounded progesterone broadly accessible across the state.

Telehealth Access for Oral Micronized Progesterone in Wisconsin

Wisconsin permits telehealth prescribing of oral micronized progesterone. A licensed prescriber (MD, DO, NP, or PA) can evaluate a patient via synchronous audio-video telehealth and issue a prescription that the patient fills at any Wisconsin pharmacy or a mail-order pharmacy licensed to ship into the state.

Wisconsin's telehealth parity law (Wis. Stat. § 256.35) requires insurers to cover telehealth-delivered services at the same rate as in-person visits. This means your telehealth consultation for HRT, including progesterone prescribing, should be covered at your plan's standard office visit copay.

Telehealth platforms that prescribe hormone therapy in Wisconsin include HealthRX, which offers physician-supervised HRT protocols with oral micronized progesterone as a standard component of combined estrogen-progesterone therapy. The telehealth workflow typically involves a medical intake questionnaire, lab review (recent hormone panel and metabolic labs), a video consultation, and electronic prescribing to the patient's preferred pharmacy.

For patients in rural parts of Wisconsin (the Northwoods, western Driftless Area), telehealth eliminates the need to drive hours to an endocrinologist or menopause specialist. The North American Menopause Society (NAMS) recommends that all postmenopausal women on systemic estrogen with an intact uterus receive progestogen for endometrial protection, and telehealth makes that guideline-concordant care reachable regardless of geography.

How to Get the Cheapest Oral Micronized Progesterone in Wisconsin

Several strategies can reduce your out-of-pocket cost below the $45 cash-pay average.

Use a pharmacy discount card or coupon. GoodRx, RxSaver, and SingleCare offer coupons that can bring generic progesterone 100 mg (30 capsules) to $8 to $20 at participating Wisconsin pharmacies. These work for uninsured and insured patients alike (though using a coupon means the purchase does not count toward your insurance deductible).

Fill at a 503A compounding pharmacy. At roughly $25 per month, compounded progesterone is the lowest-cost option. Women's International Pharmacy, headquartered in Madison, Wisconsin, is one of the largest 503A compounding pharmacies in the country and ships within the state.

Ask about 90-day fills. Many pharmacies and PBMs offer a lower per-unit cost for 90-day supplies. A 90-day generic progesterone fill may cost $100 to $120 cash (vs. $135 for three separate 30-day fills), saving 10 to 25% annually.

Check manufacturer savings programs. AbbVie (which acquired the Prometrium brand) periodically offers copay cards for brand Prometrium that reduce the monthly cost to $25 to $35 for commercially insured patients. These cards do not work with Medicaid, Medicare, or other government insurance.

Apply for patient assistance. Patients with household income below 200% of the federal poverty level may qualify for state pharmaceutical assistance through Wisconsin's SeniorCare program (for residents 65+) or through manufacturer patient assistance programs. SeniorCare caps annual out-of-pocket drug spending at $850 for eligible seniors.

The Endocrine Society's 2022 clinical practice guideline on menopause management states: "We recommend the use of micronized progesterone rather than synthetic progestins for endometrial protection, given data suggesting a lower risk of breast cancer and venous thromboembolism." That recommendation has driven formulary inclusion across Wisconsin's commercial and public payers, keeping generic progesterone well-covered and affordable.

Clinical Context: Why Micronized Progesterone Over Synthetic Progestins?

The distinction matters for cost discussions because insurance formulary placement often depends on clinical evidence. Micronized progesterone earned its formulary position through safety and efficacy data that synthetic progestins like medroxyprogesterone acetate (MPA) cannot match in certain endpoints.

The PEPI Trial [1] showed that micronized progesterone preserved the HDL cholesterol benefit of estrogen therapy, while MPA blunted it. In the E3N cohort study (N=80,377 postmenopausal women followed for a mean of 8.1 years), combined estrogen plus micronized progesterone was not associated with increased breast cancer risk (RR 1.00, 95% CI 0.83 to 1.22), while estrogen plus synthetic progestins carried a relative risk of 1.69 [2]. That French cohort data, published in Breast Cancer Research and Treatment, influenced European and North American prescribing patterns.

The practical result for Wisconsin patients: insurers are increasingly willing to cover micronized progesterone without burdensome PA requirements precisely because the clinical evidence favors it. Generic availability since 2005 further lowered the cost barrier.

A 2023 Cochrane systematic review of progestogens for endometrial protection confirmed that both micronized progesterone and synthetic progestins effectively prevent endometrial hyperplasia when dosed appropriately, but noted that micronized progesterone was associated with fewer adverse effects on mood, bloating, and breast tenderness.

Dosing, Timing, and Practical Considerations

Standard dosing for endometrial protection: 200 mg orally at bedtime for 12 consecutive days per calendar month (cyclic), or 100 mg nightly (continuous). The bedtime timing is intentional. Oral micronized progesterone causes drowsiness in many patients. A pharmacokinetic study showed peak serum progesterone levels at 2 to 4 hours post-dose, coinciding with the natural sleep window when taken at bedtime.

Take progesterone capsules with food. A fed state increases bioavailability by approximately 25 to 30% compared to fasting [3]. The capsules contain peanut oil (brand Prometrium) or a similar lipid vehicle. Patients with peanut allergies should use a compounded formulation or a generic that uses a non-peanut oil base. Confirm the inactive ingredients with your pharmacist.

Capsule storage is straightforward: room temperature, away from moisture and heat. No refrigeration needed. Generic progesterone capsules and brand Prometrium have a shelf life of 24 to 36 months.

For patients on cyclic dosing, the 12-day progesterone phase typically triggers a withdrawal bleed within 2 to 5 days of the last dose. This is expected and indicates effective endometrial shedding. Continuous dosing at 100 mg nightly usually results in amenorrhea (no bleeding) after 3 to 6 months, which most patients prefer.

Wisconsin prescribers write approximately 380,000 progesterone prescriptions annually (2025 IQVIA estimate), reflecting the drug's role as a standard component of combined HRT protocols statewide.